Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy
OBJECTIVES: Brain metastases due to breast cancer are increasing, and the prognosis is poor. Lack of effective therapy is attributed to heterogeneity of breast cancers and their resulting metastases, as well as impermeability of the blood–brain barrier (BBB), which hinders delivery of therapeutics t...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-06-01
|
| Series: | Translational Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331500025X |
| _version_ | 1828914150567313408 |
|---|---|
| author | Donna H. Murrell Amanda M. Hamilton Christiane L. Mallett Robbert van Gorkum Ann F. Chambers Paula J. Foster |
| author_facet | Donna H. Murrell Amanda M. Hamilton Christiane L. Mallett Robbert van Gorkum Ann F. Chambers Paula J. Foster |
| author_sort | Donna H. Murrell |
| collection | DOAJ |
| description | OBJECTIVES: Brain metastases due to breast cancer are increasing, and the prognosis is poor. Lack of effective therapy is attributed to heterogeneity of breast cancers and their resulting metastases, as well as impermeability of the blood–brain barrier (BBB), which hinders delivery of therapeutics to the brain. This work investigates three experimental models of HER2+ breast cancer brain metastasis to better understand the inherent heterogeneity of the disease. We use magnetic resonance imaging (MRI) to quantify brain metastatic growth and explore its relationship with BBB permeability. DESIGN: Brain metastases due to breast cancer cells (SUM190-BR3, JIMT-1-BR3, or MDA-MB-231-BR-HER2) were imaged at 3 T using balanced steady-state free precession and contrast-enhanced T1-weighted spin echo sequences. The histology and immunohistochemistry corresponding to MRI were also analyzed. RESULTS: There were differences in metastatic tumor appearance by MRI, histology, and immunohistochemistry (Ki67, CD31, CD105) across the three models. The mean volume of an MDA-MB-231-BR-HER2 tumor was significantly larger compared to other models (F2,12 = 5.845, P < .05); interestingly, this model also had a significantly higher proportion of Gd-impermeable tumors (F2,12 = 22.18, P < .0001). Ki67 staining indicated that Gd-impermeable tumors had significantly more proliferative nuclei compared to Gd-permeable tumors (t[24] = 2.389, P < .05) in the MDA-MB-231-BR-HER2 model. CD31 and CD105 staining suggested no difference in new vasculature patterns between permeable and impermeable tumors in any model. CONCLUSION: Significant heterogeneity is present in these models of brain metastases from HER2+ breast cancer. Understanding this heterogeneity, especially as it relates to BBB permeability, is important for improvement in brain metastasis detection and treatment delivery. |
| first_indexed | 2024-12-13T19:49:07Z |
| format | Article |
| id | doaj.art-0c2250707af24455b39ae05035aef3a3 |
| institution | Directory Open Access Journal |
| issn | 1936-5233 1944-7124 |
| language | English |
| last_indexed | 2024-12-13T19:49:07Z |
| publishDate | 2015-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Translational Oncology |
| spelling | doaj.art-0c2250707af24455b39ae05035aef3a32022-12-21T23:33:28ZengElsevierTranslational Oncology1936-52331944-71242015-06-018317618410.1016/j.tranon.2015.03.009Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and TherapyDonna H. Murrell0Amanda M. Hamilton1Christiane L. Mallett2Robbert van Gorkum3Ann F. Chambers4Paula J. Foster5Imaging, Robarts Research Institute, London, Ontario, CanadaImaging, Robarts Research Institute, London, Ontario, CanadaImaging, Robarts Research Institute, London, Ontario, CanadaImaging, Robarts Research Institute, London, Ontario, CanadaMedical Biophysics, Western University, London, Ontario, CanadaImaging, Robarts Research Institute, London, Ontario, CanadaOBJECTIVES: Brain metastases due to breast cancer are increasing, and the prognosis is poor. Lack of effective therapy is attributed to heterogeneity of breast cancers and their resulting metastases, as well as impermeability of the blood–brain barrier (BBB), which hinders delivery of therapeutics to the brain. This work investigates three experimental models of HER2+ breast cancer brain metastasis to better understand the inherent heterogeneity of the disease. We use magnetic resonance imaging (MRI) to quantify brain metastatic growth and explore its relationship with BBB permeability. DESIGN: Brain metastases due to breast cancer cells (SUM190-BR3, JIMT-1-BR3, or MDA-MB-231-BR-HER2) were imaged at 3 T using balanced steady-state free precession and contrast-enhanced T1-weighted spin echo sequences. The histology and immunohistochemistry corresponding to MRI were also analyzed. RESULTS: There were differences in metastatic tumor appearance by MRI, histology, and immunohistochemistry (Ki67, CD31, CD105) across the three models. The mean volume of an MDA-MB-231-BR-HER2 tumor was significantly larger compared to other models (F2,12 = 5.845, P < .05); interestingly, this model also had a significantly higher proportion of Gd-impermeable tumors (F2,12 = 22.18, P < .0001). Ki67 staining indicated that Gd-impermeable tumors had significantly more proliferative nuclei compared to Gd-permeable tumors (t[24] = 2.389, P < .05) in the MDA-MB-231-BR-HER2 model. CD31 and CD105 staining suggested no difference in new vasculature patterns between permeable and impermeable tumors in any model. CONCLUSION: Significant heterogeneity is present in these models of brain metastases from HER2+ breast cancer. Understanding this heterogeneity, especially as it relates to BBB permeability, is important for improvement in brain metastasis detection and treatment delivery.http://www.sciencedirect.com/science/article/pii/S193652331500025X |
| spellingShingle | Donna H. Murrell Amanda M. Hamilton Christiane L. Mallett Robbert van Gorkum Ann F. Chambers Paula J. Foster Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy Translational Oncology |
| title | Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy |
| title_full | Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy |
| title_fullStr | Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy |
| title_full_unstemmed | Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy |
| title_short | Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy |
| title_sort | understanding heterogeneity and permeability of brain metastases in murine models of her2 positive breast cancer through magnetic resonance imaging implications for detection and therapy |
| url | http://www.sciencedirect.com/science/article/pii/S193652331500025X |
| work_keys_str_mv | AT donnahmurrell understandingheterogeneityandpermeabilityofbrainmetastasesinmurinemodelsofher2positivebreastcancerthroughmagneticresonanceimagingimplicationsfordetectionandtherapy AT amandamhamilton understandingheterogeneityandpermeabilityofbrainmetastasesinmurinemodelsofher2positivebreastcancerthroughmagneticresonanceimagingimplicationsfordetectionandtherapy AT christianelmallett understandingheterogeneityandpermeabilityofbrainmetastasesinmurinemodelsofher2positivebreastcancerthroughmagneticresonanceimagingimplicationsfordetectionandtherapy AT robbertvangorkum understandingheterogeneityandpermeabilityofbrainmetastasesinmurinemodelsofher2positivebreastcancerthroughmagneticresonanceimagingimplicationsfordetectionandtherapy AT annfchambers understandingheterogeneityandpermeabilityofbrainmetastasesinmurinemodelsofher2positivebreastcancerthroughmagneticresonanceimagingimplicationsfordetectionandtherapy AT paulajfoster understandingheterogeneityandpermeabilityofbrainmetastasesinmurinemodelsofher2positivebreastcancerthroughmagneticresonanceimagingimplicationsfordetectionandtherapy |